FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US, Authority Hl7

16,284 resources

Type: Text:

By Version

 

Start Prev Rows 10600 - 10800 Next

PackageVersionIdentityName/TitleStatusFMMWGDate
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.199Trastuzumab Emtansine Injectableactive2021-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.200Gemtuzumab Ozogamicin Injectableactive2021-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.201Tagraxofusp Injectableactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.202Axicabtagene Ciloleucel Injectableactive2024-11
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.203BRCA1active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.204BRCA2active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.205BRCA1 Testingactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.207Epithelial Ovarian Canceractive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.208Primary Peritoneal Canceractive2022-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.209Fallopian Tube Canceractive2022-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.210Multigene Panelactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.211BRCA1 and BRCA2active2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.212BRCA1 and BRCA2 Testingactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.213BRAF V600active2022-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.214BRAF V600 Testingactive2023-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.215Colorectal Canceractive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.216BRAF V600 Mutation Statusactive2022-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.217Cancer Stage Iactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.218Head and Neck Canceractive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.219Malignant Melanoma of Skinactive2022-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.220Brain Canceractive2022-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.221Waldenstrom Macroglobulinemiaactive2024-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.222High Emetic Risk Intravenous Antineoplastic Agentactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.223Moderate Emetic Risk Intravenous Antineoplastic Agentactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.224Docetaxel Injectableactive2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.225Cyclophosphamide Injectableactive2022-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.226LAG 3 Inhibitoractive2024-11
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.233Chemotherapy Administrationactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.240Pathological N Stage N3cactive2024-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.241Audio Visual Telehealth Encounteractive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.242Moderate or High Emetic Risk Oral Antineoplastic Agentactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.243Minimal to Low Emetic Risk Oral Antineoplastic Agentactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.244Copanlisib Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.245Isatuximab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.246Loncastuximab tesirine Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.247Margetuximab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.248Mirvetuximab soravtansine Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.249Tafasitamab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.250Teclistamab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.251Tisotumab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.252Asparaginase Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.254Belantamab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.255Dostarlimab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.256Mosunetuzumab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.257Tremelimumab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.258Indication for Dexamethasoneactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.260Indication for Olanzapineactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.261Indication for Dexamethasoneactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.263Indication for Olanzapineactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.264Prednisoneactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.265As Needed PRNactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.3.266Amivantamab Injectableactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.200Doxorubicinactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.201Epirubicinactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.202Capecitabineactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.203Cyclophosphamideactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.204Injectable Fluorouracilactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.205Methotrexateactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.206Trastuzumab and Biosimilarsactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.207HER2 Presence in Tissueactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.208Carboplatinactive2020-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.209Depression Screening for Adultactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.210Long Acting Opioidsactive2020-10
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.211High Fiber Supplement or Diet Educationactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.212Dexamethasoneactive2021-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.213Olanzapineactive2021-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.214Pancreatic Canceractive2020-10
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.215Audio Visual Telehealth Encounteractive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.216Telephone Encounteractive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.217Telehealth Emergency Department or Initial Inpatientactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.218Dyspnea Assessmentactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.219Nausea or Vomiting Assessmentactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.220Karnofsky Performance Statusactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.221Referral to Hospice Careactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.222Referral to Palliative Careactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.223Palliative Careactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.224Enrollment in Hospice Careactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.225Advance Directive Including Durable Power of Attorney or Instructionalactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.229Minimal Emetic Risk Intravenous Antineoplastic Agentactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.232Epithelial Ovarian Canceractive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.233Primary Peritoneal Canceractive2022-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.235BRCA2 Testingactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.236Multigene Panelactive2023-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.237BRCA1 Testingactive2023-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.238First Line Drug Therapy for Metastatic Colorectal Canceractive2022-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.239BRAF V600 Testingactive2022-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.240Cancer Stage 4active2022-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.241Cancer Stage M1active2024-12
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.242High Emetic Risk Intravenous Antineoplastic Agentactive2022-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.243Moderate Emetic Risk Intravenous Antineoplastic Agentactive2024-10
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.245Antiemetic Agentactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.247Indication for Dexamethasoneactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.1444.5.249Indication for Olanzapineactive2025-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.2074.1.1.3Race Category Excluding Nullsactive2024-06
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1002.77Codeineactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1004.13Dihydrocodeineactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.1004.14Nalbuphineactive2020-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4009Malignant Intracranial Neoplasmactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4010Malignant Intracranial Neoplasmactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4015STEMIactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4016STEMIactive2019-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4017STEMIactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4019Fibrinolytic Therapyactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4023Cerebral Vascular Lesionactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4024Cerebral Vascular Lesionactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4025Cerebral Vascular Lesionactive2019-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4026Closed Head and Facial Traumaactive2019-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4028Aortic Dissection or Ruptured Aortic Aneurysmactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4029Acute Peptic Ulceractive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4030Acute Peptic Ulceractive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4031Acute Peptic Ulceractive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4032Dementia and Related Intracranial Pathologiesactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4033Dementia and Related Intracranial Pathologiesactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4034Active Bleeding or Bleeding Diathesis, Excluding Mensesactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4035Active Bleeding or Bleeding Diathesis, Excluding Mensesactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4036Active Bleeding or Bleeding Diathesis, Excluding Mensesactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4043Dementia and Related Intracranial Pathologiesactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4044Aortic Dissection or Ruptured Aortic Aneurysmactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4045Oral Anticoagulant Medicationsactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4046Cardiopulmonary Emergencyactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4047Cardiopulmonary Emergencyactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4048Cardiopulmonary Emergencyactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4049Mechanical Circulatory Assist Deviceactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4050Mechanical Circulatory Assist Deviceactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4052Mechanical Circulatory Assist Deviceactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4053Pregnant Stateactive2022-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4054Pregnant Stateactive2024-07
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4055Pregnant Stateactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3157.4056Major Surgical Procedureactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3566.2.1005Chronic Stable Anginaactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3566.2.1006Chronic Stable Anginaactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.3566.3.1002Chronic Stable Anginaactive2021-04
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1001Hospice Encounteractive2021-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1002Hospice Encounteractive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1003Hospice Encounteractive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1004Nutrition Servicesactive2021-09
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1005Nutrition Servicesactive2021-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1006Nutrition Servicesactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1007Hospice Care Ambulatoryactive2021-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.1008Hospice Care Ambulatoryactive2021-08
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1005Office Visitactive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1020Initial Hospital Inpatient Visitactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1030Discharge Services Hospital Inpatient Same Day Dischargeactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1035Discharge Services Hospital Inpatientactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1040Outpatient Consultationactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1050Emergency Department Evaluation and Management Visitactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1060Nursing Facility Visitactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1065Discharge Services Nursing Facilityactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1080Home Healthcare Servicesactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1110Preventive Care, Initial Office Visit, 0 to 17active2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1115Preventive Care Services Initial Office Visit, 18 and Upactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1120Preventive Care, Established Office Visit, 0 to 17active2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1125Preventive Care Services Established Office Visit, 18 and Upactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1130Preventive Care Services Individual Counselingactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1135Preventive Care Services Group Counselingactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1215Referralactive2023-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1216Face-to-Face Interactionactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1221Behavioral Health Follow up Visitactive2020-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1222Psychotherapy and Pharmacologic Managementactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1228Detoxification Visitactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1232Audiology Visitactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1233Medical Disability Examactive2019-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1260Telephone Visitsactive2025-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1261Nursing Facility Visitactive2018-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1262Care Services in Long Term Residential Facilityactive2018-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1264Office Visitactive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1265Home Healthcare Servicesactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1266Outpatient Consultationactive2020-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1276Frailty Encounteractive2019-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1277Outpatient Encounteractive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1278Outpatient Encounteractive2025-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1279Frailty Encounteractive2019-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1284Outpatient Encounteractive2023-11
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1285Palliative Encounteractive2025-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1286Palliative Encounteractive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.11.1287Telephone Visitsactive2021-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1001Office Visitactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1004Initial Hospital Inpatient Visitactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1006Discharge Services Hospital Inpatient Same Day Dischargeactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1007Discharge Services Hospital Inpatientactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1008Outpatient Consultationactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1010Emergency Department Evaluation and Management Visitactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1012Nursing Facility Visitactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1013Discharge Services Nursing Facilityactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1014Care Services in Long Term Residential Facilityactive2024-02
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1016Home Healthcare Servicesactive2024-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1022Preventive Care Services, Initial Office Visit, 0 to 17active2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1023Preventive Care Services Initial Office Visit, 18 and Upactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1024Preventive Care, Established Office Visit, 0 to 17active2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1025Preventive Care Services Established Office Visit, 18 and Upactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1026Preventive Care Services Individual Counselingactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1027Preventive Care Services Group Counselingactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1046Referralactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1048Face-to-Face Interactionactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1054Behavioral Health Follow up Visitactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1055Psychotherapy and Pharmacologic Managementactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1059Detoxification Visitactive2022-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1066Audiology Visitactive2017-05
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1073Medical Disability Examactive2021-03
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.464.1003.101.12.1080Telephone Visitsactive2025-02